Isolated y-splitting and recession of the lateral rectus muscle in patients with exo-duane syndrome.

Published

Journal Article

PURPOSE: Weakening of both horizontal rectus muscles is performed for patients with Duane syndrome and significant misinnervation of the lateral rectus (LR) muscle resulting in strabismus, limitation to ocular rotations, and globe retraction. In patients with severe up-/downshoots, a Y-splitting of the LR is often recommended. The purpose of this study was to evaluate the efficacy of isolated unilateral LR recession-Y splitting in exo-Duane patients with limitation to adduction and up-/downshoots. METHODS: etrospective review of the records of consecutive patients with exo-Duane syndrome and up/down-shoots who underwent isolated Y-splitting-recession of the affected LR. RESULTS: The records of 10 patients were reviewed (mean age at surgery 23 ± 21 years). The Y-split was performed 10 mm posterior to the insertion and was combined with a mean LR recession of 8.7 ± 2.9 mm. Torticollis decreased from 12.7 ± 4.4° to 4.8 ± 5.3° (P = 0.003). Exotropia improved from 18.4 ± 7.3 to 6.2 ± 5.9 PD postoperatively (P < 0.001). Exotropia in contralateral gaze improved from 33.7 ± 11.8 to 18.7 ± 18.1 PD postoperatively (P = 0.09). No significant postoperative changes in esotropia in ipsilateral gaze, vertical deviations, or ocular rotations in adduction or abduction were observed. Downshoots were significantly decreased (P = 0.01), and there was a trend toward improvement of upshoots (P = 0.07). There were no overcorrections, although 3 patients required additional LR weakening and transposition. CONCLUSIONS: LR Y-splitting-recession improves ocular alignment, torticollis, and up-/downshoots. LR recession improves ocular alignment and torticollis, while the addition of a Y-split procedure improves up-/downshoots.

Full Text

Duke Authors

Cited Authors

  • Velez, FG; Velez, G; Hendler, K; Pineles, SL

Published Date

  • September 2012

Published In

Volume / Issue

  • 20 / 3

Start / End Page

  • 109 - 114

PubMed ID

  • 22906380

Pubmed Central ID

  • 22906380

Electronic International Standard Serial Number (EISSN)

  • 1744-5132

Digital Object Identifier (DOI)

  • 10.3109/09273972.2012.702323

Language

  • eng

Conference Location

  • England